Antibody persistence and immune memory response following primary vaccination and boosting with live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) in Bangladesh: A phase 4 open-label clinical trial

INTRODUCTION: Japanese encephalitis (JE) virus is one of the leading causes of viral encephalitis across temperate and tropical zones of Asia. The live attenuated SA 14-14-2 JE vaccine (CD-JEV) is one of three vaccines prequalified by the World Health Organization (WHO) to prevent JE. WHO currently...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaman, K., Yunus, Md., Aziz, Asma B., Feser, Jodi, Mooney, Jessica, Tang, Yuxiao, Ellison, Damon W., Thaisomboonsuk, Butsaya, Zhang, Lei, Neuzil, Kathleen M., Marfin, Anthony A., Letson, G. William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857502/
https://www.ncbi.nlm.nih.gov/pubmed/35243320
http://dx.doi.org/10.1016/j.jvacx.2022.100143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857502/
https://www.ncbi.nlm.nih.gov/pubmed/35243320
http://dx.doi.org/10.1016/j.jvacx.2022.100143

Ejemplares similares